1. Home
  2. EDSA vs REBN Comparison

EDSA vs REBN Comparison

Compare EDSA & REBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • REBN
  • Stock Information
  • Founded
  • EDSA 2015
  • REBN 2015
  • Country
  • EDSA Canada
  • REBN United States
  • Employees
  • EDSA N/A
  • REBN N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • REBN Restaurants
  • Sector
  • EDSA Health Care
  • REBN Consumer Discretionary
  • Exchange
  • EDSA Nasdaq
  • REBN Nasdaq
  • Market Cap
  • EDSA 13.8M
  • REBN 13.5M
  • IPO Year
  • EDSA N/A
  • REBN 2022
  • Fundamental
  • Price
  • EDSA $2.08
  • REBN $2.79
  • Analyst Decision
  • EDSA Strong Buy
  • REBN
  • Analyst Count
  • EDSA 2
  • REBN 0
  • Target Price
  • EDSA $13.00
  • REBN N/A
  • AVG Volume (30 Days)
  • EDSA 15.0K
  • REBN 60.7K
  • Earning Date
  • EDSA 08-08-2025
  • REBN 08-18-2025
  • Dividend Yield
  • EDSA N/A
  • REBN N/A
  • EPS Growth
  • EDSA N/A
  • REBN N/A
  • EPS
  • EDSA N/A
  • REBN N/A
  • Revenue
  • EDSA N/A
  • REBN $6,103,732.00
  • Revenue This Year
  • EDSA N/A
  • REBN $335.98
  • Revenue Next Year
  • EDSA N/A
  • REBN N/A
  • P/E Ratio
  • EDSA N/A
  • REBN N/A
  • Revenue Growth
  • EDSA N/A
  • REBN 3.38
  • 52 Week Low
  • EDSA $1.55
  • REBN $1.03
  • 52 Week High
  • EDSA $5.59
  • REBN $8.30
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 55.28
  • REBN 55.87
  • Support Level
  • EDSA $1.99
  • REBN $2.37
  • Resistance Level
  • EDSA $2.11
  • REBN $3.00
  • Average True Range (ATR)
  • EDSA 0.11
  • REBN 0.17
  • MACD
  • EDSA 0.02
  • REBN 0.04
  • Stochastic Oscillator
  • EDSA 72.41
  • REBN 61.41

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About REBN Reborn Coffee Inc.

Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.

Share on Social Networks: